Sectoral Asset Management Inc Assembly Biosciences, Inc. Transaction History

Sectoral Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.87 - $17.29 $4.46 Million - $15.8 Million	-916,185 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $3.91 Million - $7.01 Million	259,061 Added 39.42%	916,185 $15.1 Million
Q2 2020 Aug 13, 2020	BUY	$14.57 - $23.96 $693,969 - $1.14 Million	47,630 Added 7.81%	657,124 $15.3 Million
Q1 2020 May 13, 2020	SELL	$10.27 - $21.23 $854,525 - $1.77 Million	-83,206 Reduced 12.01%	609,494 $9.04 Million
Q4 2019 Feb 12, 2020	SELL	$8.36 - $23.81 $227,358 - $647,536	-27,196 Reduced 3.78%	692,700 $14.2 Million

Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $1.26 Million - $1.89 Million	-127,800 Reduced 15.08%	719,896 $7.08 Million
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $1.7 Million - $2.74 Million	131,898 Added 18.43%	847,696 $11.4 Million
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $9.88 Million - $13.9 Million	558,398 Added 354.76%	715,798 $14.1 Million
Q4 2018 Feb 12, 2019	BUY	$19.05 - $36.45 $3 Million - $5.74 Million	157,400 New	157,400 $3.56 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $640M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.